MoneyWorks4Me

Medicamen Biotech informs about compliances certificate

18 Apr 2022 Evaluate

Medicamen Biotech has informed that it enclosed a certificate dated April 12, 2022 obtained from AMJ & Associates, Practicing Company Secretaries for the year ended March 31, 2022, pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..